FDA to pull common but ineffective cold medicine from market
The FDA says oral phenylephrine, used in many over-the-counter cough and cold medicines, "is not effective as a nasal decongestant."
FDA issue order against common ingredient found in cold and flu medicine
The US Food and Drug Administration (FDA) has proposed an order to ban a popular ingredient in cold and flu medicines as it is seemingly not as effective as other methods. Oral phenylephrine is often found in many over-the-counter cold and flu treatments,
What is oral phynylephrine and why does the FDA want to remove it from cold medicine?
Oral phenylephrine is used in over-the-counter products like Sudafed and Dayquil to help temporarily relieve the common symptom of colds and allergies. Phenylephrine has been sold for more than 75 years, predating the agency’s own regulations on drug effectiveness.
FDA seeks to pull common but ineffective OTC cold medicine ingredient off the market
Share on Facebook Share on Twitter The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off the market. Phenylephrine in many popular over-the-counter cold and allergy medications,
Which Decongestants Are Effective? Why the FDA Wants to Pull a Popular Medicine Ingredient
Phenylephrine is included in many cold and flu products, but a scientific panel last year found that it doesn't really do its job at "unstuffing" when taken by mouth.
FDA to remove ingredient from cold medicines after data shows it does not work
The U.S. Food and Drug Administration is taking the first step to remove an ingredient in non-prescription cold medicines after studies showed it does not work.
FDA to Finally Ban Controversial Ingredient in Popular Decongestants
These popular brand names appear on oral decongestants that are staples of the cold and flu aisle in American drug stores, and yet many contain an ingredient that does not work as promised. The US Food and Drug Administration (FDA) has now proposed an order to remove oral phenylephrine from every single cold,
A Popular Decongestant Doesn’t Work. The FDA Is Finally Doing Something About It
Oral phenylephrine was shown to be ineffective for treating nasal congestion over a year go. This week, the FDA took the first steps toward removing it from pharmacy shelves.
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The safety of phenylephrine isn’t a concern, but its effectiveness has been debated for years. It's found in products like Sudafed PE, Vicks DayQuil and Mucinex Sinus-Max.
FDA proposes to end use of decongestant found in cold meds
The Food and Drug Administration has proposed ending the use of a common ingredient found in many popular over-the-counter cold and allergy medications.
The buzz about Trump and psychedelics
“While President-elect Trump’s alliances may raise the visibility of psychedelics in public health discussions, we are ...
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing to remove from the ... “It is the FDA’s role to ensure that drugs ...
BioPharma Dive2h
AbbVie’s $9B bet collapses as closely watched schizophrenia drug fails studies
Shares in AbbVie slumped by double digits Monday after the company disclosed its psychiatric medicine emraclidine didn’t best ...
Drugmaker shut down after black schmutz found in injectable weight-loss drug
The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...
STAT20h
Risk of aspiration during surgery added to GLP-1 drug labels
Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at the Food and Drug ...
UPI4y
Topic: Food and Drug Administration
An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. FDA approves first once-weekly drug treatment regimen ...
Verywell Health on MSN3d
GLP-1 Drug Shortage Is Over. Why Might These Drugs Soon Be Costlier and Harder to Access?
The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...